Cargando…
Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091642/ https://www.ncbi.nlm.nih.gov/pubmed/33939101 http://dx.doi.org/10.1007/s11239-021-02471-x |
| _version_ | 1783687518394253312 |
|---|---|
| author | Eisenson, Daniel L. Owodunni, Oluwafemi P. Lau, Brandyn D. Kia, Mujan Varasteh Kraus, Peggy S. Holzmueller, Christine G. Shaffer, Dauryne L. Streiff, Michael B. Haut, Elliott R. |
| author_facet | Eisenson, Daniel L. Owodunni, Oluwafemi P. Lau, Brandyn D. Kia, Mujan Varasteh Kraus, Peggy S. Holzmueller, Christine G. Shaffer, Dauryne L. Streiff, Michael B. Haut, Elliott R. |
| author_sort | Eisenson, Daniel L. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8091642 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80916422021-05-05 Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale Eisenson, Daniel L. Owodunni, Oluwafemi P. Lau, Brandyn D. Kia, Mujan Varasteh Kraus, Peggy S. Holzmueller, Christine G. Shaffer, Dauryne L. Streiff, Michael B. Haut, Elliott R. J Thromb Thrombolysis Article Springer US 2021-05-03 2021 /pmc/articles/PMC8091642/ /pubmed/33939101 http://dx.doi.org/10.1007/s11239-021-02471-x Text en © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Article Eisenson, Daniel L. Owodunni, Oluwafemi P. Lau, Brandyn D. Kia, Mujan Varasteh Kraus, Peggy S. Holzmueller, Christine G. Shaffer, Dauryne L. Streiff, Michael B. Haut, Elliott R. Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale |
| title | Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale |
| title_full | Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale |
| title_fullStr | Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale |
| title_full_unstemmed | Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale |
| title_short | Prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for COVID-19: a cautionary tale |
| title_sort | prevalence and consequences of empiric anticoagulation for venous thromboembolism in patients hospitalized for covid-19: a cautionary tale |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091642/ https://www.ncbi.nlm.nih.gov/pubmed/33939101 http://dx.doi.org/10.1007/s11239-021-02471-x |
| work_keys_str_mv | AT eisensondaniell prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale AT owodunnioluwafemip prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale AT laubrandynd prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale AT kiamujanvarasteh prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale AT krauspeggys prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale AT holzmuellerchristineg prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale AT shafferdaurynel prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale AT streiffmichaelb prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale AT hautelliottr prevalenceandconsequencesofempiricanticoagulationforvenousthromboembolisminpatientshospitalizedforcovid19acautionarytale |